Videoconference Adapt and overcome to the Covid-19 crisis April 23, 2020
Product portfolio progression Clinical stage With Teva Pharmaceuticals • mdc-IRM (maintenance treatment of schizophrenia) • mdc-TJK (antipsychotic) With AIC • mdc-CWM (post-operative pain and inflammation) •
Product portfolio progression Next potential candidates for clinical development With the Bill & Melinda Gates Foundation • mdc-WWM (contraception) Internal products internes • mdc-GRT (Organ transplant) • mdc-NVA (Pain) • mdc-KPT (Animal Health / Pain) •
Product portfolio progression Other recent developments • mdc-CMV (surgical anaesthesia and 3 days of postoperative analgesia) With Unitaid • $ 6,4 millions grant for a a 3-month acting injectable ivermectin to neutralize the transmission vector of Malaria With the Bill & Melinda Gates Foundation • Start of activities for a product aiming at preventing HIV infection, pre- exposure prophylaxis (PrEP) •
The third path to fight Covid-19 Prevention •
Actions taken in response to the Covid-19 crisis •
Q/A You can send your questions by using the chat on the right of your screen
Thank you MedinCell www.medincell.com 3, rue des frères Lumière 34830 Jacou • France
Recommend
More recommend
